Sensor Networking Testbed with IEEE 1451 Compatibility and Network Performance Monitoring

Design and implementation of a testbed for testing and verifying IEEE 1451-compatible sensor systems with network performance monitoring is of significant importance. The performance parameters measurement as well as decision support systems implementation will enhance the understanding of sensor systems with plug-and-play capabilities. The paper will present the design aspects for such a testbed environment under development at University of Houston in collaboration with NASA Stennis Space Center - SSST (Smart Sensor System Testbed)

Ionic liquids in the electrochemical valorisation of CO2

The development of electrochemical processes for using captured CO2 in the production of valuable compounds appears as an attractive alternative to recycle CO2 and, at the same time, to store electricity from intermittent renewable sources. Among the different innovative attempts that are being investigated to improve these processes, the application of ionic liquids (ILs) has received growing attention in recent years. This paper presents a unified discussion of the significant work that involves the utilisation of ILs for the valorisation of CO2 by means of electrochemical routes. We discuss studies in which CO2 is used as one of the reactants to electrosynthesise value-added products, among which dimethyl carbonate has been the focus of particular attention in the literature. Approaches based on the electrochemical reduction of CO2 to convert it into products without the use of other carbon-based reactants are also reviewed, highlighting the remarkable improvements that the use of ILs has allowed in the CO2 electroreduction to CO. The review emphasises on different aspects related to process design, including the nature of IL anions and cations that have been used, the working conditions, the electrocatalytic materials, the electrode configurations, or the design of electrochemical cells, as well as discussing the most relevant observations, results and figures of merit that the participation of ILs has allowed to achieve in these processes. Several conclusions are finally proposed to highlight crucial challenges and recommendations for future research in this area.The financial support from the Spanish Ministry of Economy and Competitiveness Project CTQ2013-48280-C3-1-R is gratefully acknowledged. J. Albo particularly thanks Juan de la Cierva program (JCI-2012-12073)

Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules

Seventy-five percent of patients with epithelial ovarian cancer present with advanced-stage disease that is extensively disseminated intraperitoneally and prognosticates the poorest outcomes. Primarily metastatic within the abdominal cavity, ovarian carcinomas initially spread to adjacent organs by direct extension and then disseminate via the transcoelomic route to distant sites. Natural fluidic streams of malignant ascites triggered by physiological factors, including gravity and negative subdiaphragmatic pressure, carry metastatic cells throughout the peritoneum. We investigated the role of fluidic forces as modulators of metastatic cancer biology in a customizable microfluidic platform using 3D ovarian cancer nodules. Changes in the morphological, genetic, and protein profiles of biomarkers associated with aggressive disease were evaluated in the 3D cultures grown under controlled and continuous laminar flow. A modulation of biomarker expression and tumor morphology consistent with increased epithelial–mesenchymal transition, a critical step in metastatic progression and an indicator of aggressive disease, is observed because of hydrodynamic forces. The increase in epithelial–mesenchymal transition is driven in part by a posttranslational up-regulation of epidermal growth factor receptor (EGFR) expression and activation, which is associated with the worst prognosis in ovarian cancer. A flow-induced, transcriptionally regulated decrease in E-cadherin protein expression and a simultaneous increase in vimentin is observed, indicating increased metastatic potential. These findings demonstrate that fluidic streams induce a motile and aggressive tumor phenotype. The microfluidic platform developed here potentially provides a flow-informed framework complementary to conventional mechanism-based therapeutic strategies, with broad applicability to other lethal malignancies.National Institutes of Health (U.S.) (Grant R21-HL112114)National Institutes of Health (U.S.) (Grant R21-AI087107)National Institutes of Health (U.S.) (Grant R01AI081534)National Institutes of Health (U.S.) (Grant R01EB015776)National Institutes of Health (U.S.) (Grant R01CA158415)National Institutes of Health (U.S.) (Grant R01CA160998)National Institutes of Health (U.S.) (Grant 5PO1CA084203)National Science Foundation (U.S.) (CAREER Award 1150733

Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD

Nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiovascular disease. Because the liver is the major source of circulatory proteins, it is not surprising that hepatic disease could lead to alterations in the plasma proteome, which are therein implicated in atherosclerosis. The current study used low-density lipoprotein receptor-deficient (LDLR^–/–) mice to examine the impact of Western diet (WD)-induced NAFLD on plasma proteome homeostasis. Using a ²H₂O-metabolic labeling method, we found that a WD led to a proinflammatory distribution of circulatory proteins analyzed in apoB-depleted plasma, which was attributed to an increased production. The fractional turnover rates of short-lived proteins that are implicated in stress-response, lipid metabolism, and transport functions were significantly increased with WD (<i>P</i> < 0.05). Pathway analyses revealed that alterations in plasma proteome dynamics were related to the suppression of hepatic PPARα, which was confirmed based on reduced gene and protein expression of PPARα in mice fed a WD. These changes were associated with ∼4-fold increase (<i>P</i> < 0.0001) in the proinflammatory property of apoB-depleted plasma. In conclusion, the proteome dynamics method reveals proinflammatory remodeling of the plasma proteome relevant to liver disease. The approach used herein may provide a useful metric of in vivo liver function and better enable studies of novel therapies surrounding NAFLD and other diseases

Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD

Nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiovascular disease. Because the liver is the major source of circulatory proteins, it is not surprising that hepatic disease could lead to alterations in the plasma proteome, which are therein implicated in atherosclerosis. The current study used low-density lipoprotein receptor-deficient (LDLR^–/–) mice to examine the impact of Western diet (WD)-induced NAFLD on plasma proteome homeostasis. Using a ²H₂O-metabolic labeling method, we found that a WD led to a proinflammatory distribution of circulatory proteins analyzed in apoB-depleted plasma, which was attributed to an increased production. The fractional turnover rates of short-lived proteins that are implicated in stress-response, lipid metabolism, and transport functions were significantly increased with WD (<i>P</i> < 0.05). Pathway analyses revealed that alterations in plasma proteome dynamics were related to the suppression of hepatic PPARα, which was confirmed based on reduced gene and protein expression of PPARα in mice fed a WD. These changes were associated with ∼4-fold increase (<i>P</i> < 0.0001) in the proinflammatory property of apoB-depleted plasma. In conclusion, the proteome dynamics method reveals proinflammatory remodeling of the plasma proteome relevant to liver disease. The approach used herein may provide a useful metric of in vivo liver function and better enable studies of novel therapies surrounding NAFLD and other diseases

Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma

Studies on the efficacy of small molecule inhibitors in Merkel cell carcinoma (MCC) have been limited and largely inconclusive. In this study, we investigated the therapeutic potential of a potent BET degrader, BETd-246, in the treatment of MCC. We found that MCC cell lines were significantly more sensitive to BETd-246 than to BET inhibitor treatment. Therapeutic targeting of BET proteins resulted in a loss of “MCC signature” genes but not MYC expression as previously described irrespective of Merkel cell polyomavirus (MCPyV) status. In MCPyV+ MCC cells, BETd-246 alone suppressed downstream targets in the MCPyV-LT Ag axis. We also found enrichment of HOX and cell cycle genes in MCPyV− MCC cell lines that were intrinsically resistant to BETd-246. Our findings uncover a requirement for BET proteins in maintaining MCC lineage identity and point to the potential utility of BET degraders for treating MCC